Makers Laboratories Limited

BSE:506919 Stock Report

Market Cap: ₹818.4m

Makers Laboratories Past Earnings Performance

Past criteria checks 0/6

Makers Laboratories has been growing earnings at an average annual rate of 6.8%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 8.9% per year.

Key information

6.84%

Earnings growth rate

4.04%

EPS growth rate

Pharmaceuticals Industry Growth17.49%
Revenue growth rate8.85%
Return on equity3.34%
Net Margin-0.017%
Last Earnings Update30 Sep 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Makers Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:506919 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 251,30801540
30 Jun 251,262891500
31 Mar 251,208751490
31 Dec 241,147631440
30 Sep 241,135501460
30 Jun 241,090-521460
31 Mar 241,044-631440
31 Dec 231,060-531370
30 Sep 23994-591320
30 Jun 231,008-521260
31 Mar 231,013-481210
31 Dec 221,009-511230
30 Sep 221,105-81250
30 Jun 221,176151260
31 Mar 221,282501280
31 Dec 211,322581260
30 Sep 211,169231130
30 Jun 21964151020
31 Mar 21686-3900
31 Dec 20502-2810
30 Sep 2046611800
30 Jun 205035820
31 Mar 20514-1820
31 Dec 194683790
30 Sep 194573780
30 Jun 194279760
31 Mar 1946624740
31 Dec 1852125750
30 Sep 1856033710
30 Jun 1858942660
31 Mar 1855931660
31 Dec 1756822640
30 Sep 1755827650
30 Jun 1756621680
31 Mar 1757837670
31 Dec 1658231800
30 Sep 1658227810
30 Jun 1656721-20
31 Mar 1661423810
31 Dec 15608271450
30 Sep 15630291450
30 Jun 15653311470
31 Mar 1564924720
31 Dec 14675161550

Quality Earnings: 506919 is currently unprofitable.

Growing Profit Margin: 506919 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 506919 is unprofitable, but has reduced losses over the past 5 years at a rate of 6.8% per year.

Accelerating Growth: Unable to compare 506919's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 506919 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (15.8%).

Return on Equity

High ROE: 506919 has a negative Return on Equity (3.34%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/16 06:30
End of Day Share Price 2025/11/14 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Makers Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research